Delivery Order SPE2DB22D9143-SPE2DB25FZC62
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $5,207.70 with an ultimate completion date of August 21, 2025, was issued without a set-aside designation. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a task order under the company's larger single-award Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $17,851.68 firm fixed-price delivery order by the Defense Logistics Agency on August 25, 2025, for Mirena 52 mg systems with an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation and represents part of DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 21, 2025, for Mirena 52 mg systems with a ceiling value of $6,249.24. This firm fixed-price delivery order, which is expected to be completed by August 11, 2025, was awarded without a set-aside designation. The award represents a continuation of the company's role as a critical supplier within...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,623.10 by the Defense Logistics Agency (DLA) on August 15, 2025, for Mirena 52 mg systems. The award carries an ultimate completion date of September 8, 2025, and includes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,249.24 by the Defense Logistics Agency on August 21, 2025, for Mirena 52 mg systems. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $2,603.85 by the Defense Logistics Agency (DLA) for Mirena 52 mg contraceptive systems. The delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a tactical procurement under the DLA's broader pharmaceutical supply infrastructure. This award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,603.85 for Mirena 52 mg systems on August 28, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply to the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $2,603.85, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract involves no set-aside designation and is...
- SPE2DB22D9143Indefinite Delivery Contract
- SPE2DB22D9143-SPE2DB25FZC62Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $26,038.50 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, which is scheduled for completion by September 22, 2025, was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The award represents a specific fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. Mirena systems are hormonal intrauterine contraceptive devices commonly utilized in military and federal healthcare settings. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, maintaining a robust portfolio of federal contract awards that span prescription medications, biologics, and medical consumables. The company's consistent success in securing delivery orders through the DLA's SPE2DB program demonstrates its reliability as a primary distributor of specialty pharmaceutical products to military health facilities across the nation. This delivery order aligns with the contractor's core business of providing direct pharmaceutical distribution and pharmacy services to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 8/29/25 |